Icon selects AG Mednet to give trial sponsors zero-delay efficiency

Wednesday, June 27, 2012 09:23 AM

AG Mednet has signed an OEM agreement with Icon Medical Imaging, a division of Icon, further embedding AG Mednet’s quality control, compliance, de-identification and image transfer technology into Icon’s imaging trial offerings.

AG Mednet provides the quality assurance and compliance technology necessary for clinical trials to operate with zero delay. The OEM partnership with AG Mednet provides Icon Medical Imaging with early insight into AG Mednet technology advancements for expanded capabilities, and will provide Icon’s imaging clients with a more efficient, compliant and cost-effective clinical trial system to expedite the clinical trial decision-making process. 

AG Mednet’s technology and services will integrate with Icon’s MIRA and CTMS to provide sponsors and sites with the most advanced image data collection and delivery system in the market. AG Mednet supports all organizations in the clinical trial ecosystem: core labs, clinical research organizations, pharmaceutical companies and principal investigators.  

“This OEM agreement is the culmination of years of collaboration and hard work between our companies,” said Abraham Gutman, president and CEO of AG Mednet. “Icon Medical Imaging has a far-reaching quality management vision that will reduce the burden on sites, increase trial efficiency and strengthen protocol compliance across all therapeutic areas.” 

Share:          
CWWeekly

July 27

AB Science warned about putting study volunteers in danger

FDA, Google unite to detect search-data adverse events

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs